KE3623A - Stable solutions of hydrogenated ergotalkaloids - Google Patents

Stable solutions of hydrogenated ergotalkaloids

Info

Publication number
KE3623A
KE3623A KE3623A KE362386A KE3623A KE 3623 A KE3623 A KE 3623A KE 3623 A KE3623 A KE 3623A KE 362386 A KE362386 A KE 362386A KE 3623 A KE3623 A KE 3623A
Authority
KE
Kenya
Prior art keywords
ergotalkaloids
hydrogenated
stable solutions
solutions
stable
Prior art date
Application number
KE3623A
Inventor
Hartmann Volker
Otto Karl-Heinz
Patt Ludwig
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of KE3623A publication Critical patent/KE3623A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/02—Ergot alkaloids of the cyclic peptide type

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
KE3623A 1979-11-12 1986-04-14 Stable solutions of hydrogenated ergotalkaloids KE3623A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792945636 DE2945636A1 (en) 1979-11-12 1979-11-12 STABLE SOLUTIONS OF HYDRATED ERGOTAL CALOIDS OR YOUR SALTS AND HEPARIN OR ITS SALTS AND METHOD FOR THE PRODUCTION THEREOF

Publications (1)

Publication Number Publication Date
KE3623A true KE3623A (en) 1986-05-16

Family

ID=6085779

Family Applications (1)

Application Number Title Priority Date Filing Date
KE3623A KE3623A (en) 1979-11-12 1986-04-14 Stable solutions of hydrogenated ergotalkaloids

Country Status (22)

Country Link
EP (1) EP0028813B1 (en)
JP (1) JPS5686116A (en)
AT (1) AT371997B (en)
AU (1) AU535357B2 (en)
BE (1) BE886008A (en)
CA (1) CA1165692A (en)
CH (1) CH650930A5 (en)
CY (1) CY1332A (en)
DE (2) DE2945636A1 (en)
DK (1) DK155144C (en)
FI (1) FI72045C (en)
GB (1) GB2062468B (en)
GR (1) GR72128B (en)
HK (1) HK40386A (en)
HU (1) HU183244B (en)
IE (1) IE50372B1 (en)
IL (1) IL61447A (en)
KE (1) KE3623A (en)
MY (1) MY8500165A (en)
PH (1) PH22800A (en)
PT (1) PT72041B (en)
ZA (1) ZA807005B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3227122A1 (en) * 1982-07-20 1984-01-26 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim STABLE SOLUTIONS OF MOTHER CORNAL CALOIDS
CH656533A5 (en) * 1982-12-10 1986-07-15 Sandoz Ag THERAPEUTIC PREPARATION CONTAINING HYDRATED ERGOTAL CALOIDS AND LOW MOLECULAR HEPARINE.
DE3432661A1 (en) * 1984-09-05 1986-03-06 Albert Prof. Dr. 6907 Nußloch Landsberger CARCINOM THERAPEUTIC
AT381232B (en) * 1985-05-13 1986-09-10 Kwizda Fa F Johann METHOD FOR PRODUCING STABLE LIQUID SOLUTIONS OF ERGOL DERIVATIVES
PL373033A1 (en) * 2002-06-20 2005-08-08 Novartis Consumer Health S.A. Nasal compositions comprising a mucopolysaccharide and propylene glycol

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2735587A1 (en) * 1977-08-06 1979-02-15 Sandoz Ag STABLE SOLUTIONS AND METHOD FOR THEIR PRODUCTION
DE2625403A1 (en) * 1976-06-05 1977-12-08 Sandoz Ag Antithrombotic association of medicaments - contains heparin and an ergoline-(8)-carboxylic acid peptidic amide esp. dihydroergotamine opt. with polyvinyl pyrrolidone
DE2809618A1 (en) * 1978-03-06 1979-09-20 Sandoz Ag NEW THERAPEUTIC PREPARATION AND METHOD FOR THE PRODUCTION THEREOF
DE2555481C3 (en) * 1975-12-10 1985-10-03 Sandoz-Patent-GmbH, 7850 Lörrach Production of stable drop solutions of hydrogenated ergot alkaloids
DE2945677A1 (en) * 1979-11-12 1981-05-21 Sandoz-Patent-GmbH, 7850 Lörrach Antithrombotic combination of di:hydro:ergotamine cpd. and heparin - administered using a two-chamber system syringe to avoid instability problems on prolonged storage

Also Published As

Publication number Publication date
ZA807005B (en) 1982-06-30
CH650930A5 (en) 1985-08-30
AT371997B (en) 1983-08-25
ATA550480A (en) 1983-01-15
HU183244B (en) 1984-04-28
PT72041A (en) 1980-12-01
IE50372B1 (en) 1986-04-02
DK155144B (en) 1989-02-20
DE2945636A1 (en) 1981-05-21
GB2062468A (en) 1981-05-28
IE802340L (en) 1981-05-12
FI72045B (en) 1986-12-31
IL61447A0 (en) 1980-12-31
GR72128B (en) 1983-09-16
IL61447A (en) 1983-11-30
DK477880A (en) 1981-05-13
JPS5686116A (en) 1981-07-13
PH22800A (en) 1988-12-12
AU535357B2 (en) 1984-03-15
FI803456L (en) 1981-05-13
AU6426580A (en) 1981-05-21
BE886008A (en) 1981-05-04
EP0028813A3 (en) 1982-08-25
CA1165692A (en) 1984-04-17
PT72041B (en) 1982-01-26
GB2062468B (en) 1983-08-24
DE3068719D1 (en) 1984-08-30
JPH021126B2 (en) 1990-01-10
CY1332A (en) 1986-06-27
FI72045C (en) 1987-04-13
MY8500165A (en) 1985-12-31
HK40386A (en) 1986-06-06
DK155144C (en) 1989-07-03
EP0028813A2 (en) 1981-05-20
EP0028813B1 (en) 1984-07-25

Similar Documents

Publication Publication Date Title
ZA807631B (en) Oligomrtization of oleffins
JPS55106264A (en) Manufacture of benzimidazolylbenzofurans
JPS5797083A (en) Accerelation of matter
JPS5612360A (en) Manufacture of oosubstituteddketoxime
JPS55126123A (en) Holder of balllanddroller bearing
JPS5653648A (en) Direct manufacture of betaamethylthiopropionealdehyde
JPS55104469A (en) Selffwatch of solution
JPS55154968A (en) Manufacture of epsilonncaprolactone
JPS55137115A (en) Manufacture of carboxyllatex
JPS55130966A (en) Manufacture of thiazolidinee22thione
JPS55133361A (en) Manufacture of hydroxyethylazoles
JPS55141480A (en) Manufacture of butyrolactone
DE2964978D1 (en) Use of benzyl-phenols as antioxidants
ZA807005B (en) Stable solutions of hydrogenated ergotalkaloids
AU539788B2 (en) Hydrogenation of tar-sands
JPS55125156A (en) Manufacture of 11aminoo22phenoxyy44hydroxyyanthraquinone
JPS55111464A (en) Manufacture of 77acylindolinee22one
JPS5610473A (en) Structure of printingghammer
DE3071091D1 (en) Stable aqueous solutions of alloxane
JPS55160770A (en) Manufacture of hexafluorotriarylisocyanurate
JPS5640623A (en) Hydrogenation of arylether
JPS5612388A (en) Manufacture of pyrenzepin
JPS5610177A (en) Manufacture of 22isopropylaminopyrimidine
JPS56123967A (en) Manufacture of omegaalactam
JPS55157555A (en) Manufacture of alphaacyanoobenzylester